519 related articles for article (PubMed ID: 17623709)
41. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
[TBL] [Abstract][Full Text] [Related]
42. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
[TBL] [Abstract][Full Text] [Related]
43. Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies.
Na M; Yiyun C; Tongwen X; Yang D; Xiaomin W; Zhenwei L; Zhichao C; Guanyi H; Yunyu S; Longping W
Eur J Med Chem; 2006 May; 41(5):670-4. PubMed ID: 16527374
[TBL] [Abstract][Full Text] [Related]
44. A matrix reservoir for improved control of non-viral gene delivery.
Holladay C; Keeney M; Greiser U; Murphy M; O'Brien T; Pandit A
J Control Release; 2009 Jun; 136(3):220-5. PubMed ID: 19233237
[TBL] [Abstract][Full Text] [Related]
45. Evaluating the gene-expression profiles of HeLa cancer cells treated with activated and nonactivated poly(amidoamine) dendrimers, and their DNA complexes.
Kuo JH; Liou MJ; Chiu HC
Mol Pharm; 2010 Jun; 7(3):805-14. PubMed ID: 20394435
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.
Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L
Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123
[TBL] [Abstract][Full Text] [Related]
47. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine.
Choi JS; Nam K; Park JY; Kim JB; Lee JK; Park JS
J Control Release; 2004 Oct; 99(3):445-56. PubMed ID: 15451602
[TBL] [Abstract][Full Text] [Related]
48. Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications.
Yellepeddi VK; Kumar A; Palakurthi S
Expert Opin Drug Deliv; 2009 Aug; 6(8):835-50. PubMed ID: 19637972
[TBL] [Abstract][Full Text] [Related]
49. Dendrimer/DNA complexes encapsulated functional biodegradable polymer for substrate-mediated gene delivery.
Fu HL; Cheng SX; Zhang XZ; Zhuo RX
J Gene Med; 2008 Dec; 10(12):1334-42. PubMed ID: 18816481
[TBL] [Abstract][Full Text] [Related]
50. DNA condensation by PAMAM dendrimers: self-assembly characteristics and effect on transcription.
Fant K; Esbjörner EK; Lincoln P; Nordén B
Biochemistry; 2008 Feb; 47(6):1732-40. PubMed ID: 18189415
[TBL] [Abstract][Full Text] [Related]
51. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
[TBL] [Abstract][Full Text] [Related]
52. Bundling and aggregation of DNA by cationic dendrimers.
Froehlich E; Mandeville JS; Weinert CM; Kreplak L; Tajmir-Riahi HA
Biomacromolecules; 2011 Feb; 12(2):511-7. PubMed ID: 21192723
[TBL] [Abstract][Full Text] [Related]
53. [The effect of polyamidoamine (PAMAM) dendrimers on the solubility and pharmacokinetics of breviscapine].
Lu JJ; Wu ZH; Ping QN
Yao Xue Xue Bao; 2009 Feb; 44(2):197-202. PubMed ID: 19408693
[TBL] [Abstract][Full Text] [Related]
54. Optimization and in vitro toxicity evaluation of G4 PAMAM dendrimer-risperidone complexes.
Prieto MJ; Temprana CF; del Río Zabala NE; Marotta CH; Alonso Sdel V
Eur J Med Chem; 2011 Mar; 46(3):845-50. PubMed ID: 21251731
[TBL] [Abstract][Full Text] [Related]
55. Dendritic polyamines: simple access to new materials with defined treelike structures for application in nonviral gene delivery.
Krämer M; Stumbé JF; Grimm G; Kaufmann B; Krüger U; Weber M; Haag R
Chembiochem; 2004 Aug; 5(8):1081-7. PubMed ID: 15300831
[TBL] [Abstract][Full Text] [Related]
56. Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo.
Navarro G; Tros de Ilarduya C
Nanomedicine; 2009 Sep; 5(3):287-97. PubMed ID: 19523431
[TBL] [Abstract][Full Text] [Related]
57. Preferential liver gene expression with polypropylenimine dendrimers.
Schatzlein AG; Zinselmeyer BH; Elouzi A; Dufes C; Chim YT; Roberts CJ; Davies MC; Munro A; Gray AI; Uchegbu IF
J Control Release; 2005 Jan; 101(1-3):247-58. PubMed ID: 15588909
[TBL] [Abstract][Full Text] [Related]
58. Biodegradable PAMAM ester for enhanced transfection efficiency with low cytotoxicity.
Nam HY; Nam K; Hahn HJ; Kim BH; Lim HJ; Kim HJ; Choi JS; Park JS
Biomaterials; 2009 Feb; 30(4):665-73. PubMed ID: 18996585
[TBL] [Abstract][Full Text] [Related]
59. A dendrimer-like DNA-based vector for DNA delivery: a viral and nonviral hybrid approach.
Luo D; Li Y; Um SH; Cu Y
Methods Mol Med; 2006; 127():115-25. PubMed ID: 16988451
[TBL] [Abstract][Full Text] [Related]
60. Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity.
Shakhbazau A; Isayenka I; Kartel N; Goncharova N; Seviaryn I; Kosmacheva S; Potapnev M; Shcharbin D; Bryszewska M
Int J Pharm; 2010 Jan; 383(1-2):228-35. PubMed ID: 19770028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
